The FDA has approved a new HIV treatment for patients with limited treatment options.
Blog
-
-
Kymriah, the first FDA-approved CAR-T cell therapy, is showing promising results in treating children with acute lymphoblastic leukemia.
-
February 27, 2018
The Food and Drug Administration (FDA) have extended the approval of Verzenio (abemaciclib) to now be a first line treatment for some types of advanced or metastatic breast cancer.
-
February 22, 2018
The UK institute NICE gives 3 nods in thyroid cancer: Cometriq (cabozantinib), Nexavar (sorafenib) and Lenvima (lenvatinib).
-
February 22, 2018
FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions.
-
February 22, 2018
Imfinzi (durvalumab), already approved for some bladder cancers, is now FDA approved for some patients with lung cancer.
-
February 19, 2018
Price decreases for 38 medicines
-
In a recent trial, 80% of patients with (MRD)-positive acute lymphoblastic leukemia (ALL) who were treated with a drug called Blincyto (blinatumomab) achieved a complete response.
-
February 15, 2018
The FDA has approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread, but that continues to grow despite treatment with hormone therapy.
-
The Scottish Medicines Consortium (SMC) has approved Mavenclad (cladribine) as a treatment for highly active relapsing multiple sclerosis.
-
Scientists experimenting with an innovative treatment for cancer have now devised a targeted injection that has already successfully eliminated tumours in mice.
-
February 07, 2018
The first ever patient to be treated with a new type of CAR-T cell therapy in a novel clinical trial is now in remission.
-
February 06, 2018
Remember the hypospray from Star Trek? Maybe it's close to reality.
-
February 02, 2018
A new combination of medicines is showing positive results in ER/HER2-Positive breast cancer.
-
The experimental drug from Roche (balovaptan) has now been given Breakthrough Therapy Designation, potentially placing the drug on a faster path to market as the first pharmacological treatment for autism spectrum disorder (ASD). Pharmatimes, 30/01/2018.
-
January 29, 2018
Following the EMA’s approval in late 2017, the FDA has now also approved Lutathera (lutetium Lu 177 dotatate) for certain digestive tract cancers.
-
January 29, 2018
The potential of neuroprotective agents for a whole new form of treatment.
-
January 26, 2018
A list of medicines TheSocialMedwork will soon be making available.
-
January 25, 2018
New test detects ovarian and 7 other cancers using simple blood sample.
-
Brentuximab vedotin (Adcetris) has now been approved by the European Commission for the treatment of patients with CD30-positive cutaneous T-cell lymphoma (CTCL) who have had at least 1 prior systemic therapy.
-
January 18, 2018
Lynparza (olaparib) is the first PARP inhibitor approved to treat breast cancer, and the first medicine ever for metastatic breast cancer who have a “BRCA” gene mutation.
-
January 15, 2018
Ocrevus (ocrelizumab), the first ever FDA approved medicine for primary progressive MS has now also been approved by the EMA.
-
January 14, 2018
A new study found that cabozantinib (Cabometyx) was more effective than everolimus in advanced renal cell carcinoma and bone metastases.
-
January 07, 2018
Pembrolizumab showed positive results in heavily pretreated, PD-L1–positive advanced esophageal carcinoma.
-
Specific strains of intestinal bacteria can improve the response rate to immunotherapy for patients being treated for advanced melanoma.
-
December 30, 2017
Eight important updates in lung cancer.
-
December 21, 2017
Darzalex (daratumumab) combination under review as first-line option.
-
Immunotherapy nivolumab has been linked to HIV reservoir decrease in a lung cancer patient.
-
December 07, 2017
In a pilot study immunotherapy proved active in some patients with metastatic, trastuzumab (Herceptin)-resistant HER2-positive breast cancer.
-
December 06, 2017
Is there substance to the claims that it's a groundbreaking treatment?